ERISstockERIS Lifesciences Ltd
₹1,407.45
▲+2.21%
Open
₹1,377.4
High
₹1,415
Low
₹1,377.4
Volume
49.3K
Price chart
Daily close · downsampled 5-year history
2021-06-21 · ₹711.152026-06-18 · ₹1,433
Instrument details
- MB Code
- MBEQU2612
- Type
- stock
- ISIN
- INE406M01024
- BSE
- 540596
- Industry
- Pharmaceuticals & Biotechnology
Latest earnings
Q4FY26 declared
- Quarter
- Mar 2026
- Revenue
- 756.56 Cr
- Net profit
- 279.1 Cr
- EPS
- 20.57
- YoY revenue
- +7.27%
Price returns
Historical performance
- 1 day
- +1.62%
- 1 month
- +7.15%
- 3 months
- +10.99%
- 1 year
- -19.43%
- 3 years
- +111.73%
- 5 years
- +101.11%
Technicals
Indicator consensus
Bullish
34
Neutral
3
Bearish
9
RSI 70.32(Bearish)
Company documents
Annual reports, concalls, presentations
Concall transcripts
28Investor presentations
74Corporate announcements
290Corporate timeline
Price chart events · 1 year
Dividend
2026-05-29
{"amount":7.21}
Earnings
2026-02-13
{"actualRevenue":8074500000,"estimateRevenue":8385000000,"revenueSurprise":-310500000,"revenueSurprisePercent":-3.70304114490161,"actualEPS":8.6,"estimateEPS":10.608,"surprise":-2.008000000000001,"surprisePercent":-18.9291101055807}
Earnings
2026-05-20
{"actualRevenue":7565600000,"estimateRevenue":8396000000,"revenueSurprise":-830400000,"revenueSurprisePercent":-9.890424011434016,"actualEPS":20.57,"estimateEPS":10.2,"surprise":10.37,"surprisePercent":101.6666666666667}
Earnings
2025-08-05
{"actualRevenue":7730000000,"estimateRevenue":8060000000,"revenueSurprise":-330000000,"revenueSurprisePercent":-4.094292803970223,"actualEPS":8.64,"estimateEPS":8.363999999999999,"surprise":0.2760000000000016,"surprisePercent":3.299856527977064}
News
2026-05-20
{"description":"Eris Lifesciences Q4FY26 net profit nearly tripled to ₹281.6 crore on a ₹132.2 crore deferred tax gain; revenue rose 7.3% and the board declared ₹7.21 interim dividend, record date May 29, 2026.","url":"https://www.cnbctv18.com/market/earnings/eris-lifesciences-q4-results-branded-formulations-semaglutide-pens-margins-fy27-share-price-ws-el-19909994.htm","sentiment":"Positive","domain":"CNBCTV18"}
News
2026-05-20
{"description":"Eris Lifesciences rose 8.57% after reporting Q4 FY26 consolidated PAT jumped 200.09% YoY to Rs 281.61 crore from Rs 93.84 crore in Q4 FY25.","url":"https://www.business-standard.com/markets/capital-market-news/eris-lifesciences-spurts-after-q4-pat-skyrockets-200-yoy-to-rs-282-cr-126052000830_1.html","sentiment":"Positive","domain":"Business Standard"}
News
2025-08-06
{"description":"Prabhudas Lilladher recommends a buy on Eris Lifesciences with a target price of Rs 1975.","url":"https://www.moneycontrol.com/news/business/stocks/buy-eris-lifesciences-target-of-rs-1975-prabhudas-lilladher-13402319.html","sentiment":"Positive","domain":"Moneycontrol"}
News
2025-06-21
{"description":"Eris Lifesciences' share price is currently ₹1624.1 on the BSE. The stock has seen fluctuations today, indicating market volatility.","url":"https://www.financialexpress.com/market/eris-lifesciences-ltd-share-price/","sentiment":"Neutral","domain":"The Financial Express"}